Cargando…

A 37-Year-Old Woman with Hypertrophic Cardiomyopathy with a Dual-Chamber Implantable Cardioverter-Defibrillator Requiring Percutaneous Transvenous Lead Extraction and Multidisciplinary Management

Patient: Female, 37-year-old Final Diagnosis: Hypertrophic cardiomyopathy Symptoms: None Medication:— Clinical Procedure: Percutaneous ICD lead extraction • Surgical ICD lead extraction Specialty: Cardiac Electrophysiology • Cardiac Surgery • Cardiology OBJECTIVE: Diagnostic/therapeutic accidents BA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhawan, Rahul, Khan, Faris, Samant, Saurabhi, Asawaeer, Majid, Genore, HelenMari Merritt, Erickson, Christopher C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546269/ https://www.ncbi.nlm.nih.gov/pubmed/34675166 http://dx.doi.org/10.12659/AJCR.932073

Ejemplares similares

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Epicardial vs. transvenous implantable cardioverter defibrillators in children
por: Le Bos, Pierre Antoine, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Forces Applied during Transvenous Implantable Cardioverter Defibrillator Lead Removal
por: Lennerz, Carsten, et al.
Publicado: (2014)

Transvenous Implantable Cardioverter-Defibrillator Lead Reliability: Implications for Postmarket Surveillance
por: Kramer, Daniel B, et al.
Publicado: (2015)

State‐of‐the‐art consensus on non‐transvenous implantable cardioverter‐defibrillator therapy
por: Schukro, Christoph, et al.
Publicado: (2020)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Comparison of quality-of-life measures in patients with transvenous and subcutaneous implantable cardioverter-defibrillators
por: Ferrick, Aileen M., et al.
Publicado: (2023)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

Lead failure in transvenous implantable cardioverter defibrillator: a new opportunity for an effective management
por: Pignalberi, Carlo, et al.
Publicado: (2018)

Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients
por: Quast, A. B. E., et al.
Publicado: (2018)

Transvenous shock‐only implantable cardioverter defibrillator after an atrio‐pulmonary Fontan surgery
por: Toyohara, Keiko, et al.
Publicado: (2020)

Transvenous Implantable Cardioverter‐Defibrillator (ICD) Lead Performance: A Meta‐Analysis of Observational Studies
por: Providência, Rui, et al.
Publicado: (2015)

Commentary: Rome wasn't built in a day: Learning from initial cohort studies for patients with coronavirus disease receiving extracorporeal membrane oxygenation
por: Merritt-Genore, HelenMari, et al.
Publicado: (2022)

Commentary: Help wanted! Replicating on-the-job surgical education during the pandemic
por: Merritt-Genore, HelenMari, et al.
Publicado: (2021)

Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator
por: Francia, Pietro, et al.
Publicado: (2023)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

Transvenous implantable cardioverter-defibrillator implantation in a patient with arrhythmogenic cardiomyopathy and massive right atrial thrombus
por: Hayashi, Hiroshi, et al.
Publicado: (2020)

Delayed perforation of the right ventricle by cardioverter-defibrillator lead – safe transvenous lead extraction by mechanical systems
por: Ząbek, Andrzej, et al.
Publicado: (2023)

Two Limitations of Subcutaneous Implantable Cardioverter Defibrillator in the Same Patient Warranting Its Explant
por: Dhawan, Rahul, et al.
Publicado: (2021)

Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy
por: Goldstein, Sarah A., et al.
Publicado: (2023)

High-voltage impedance rise; mechanism and management in patients with transvenous implantable cardioverter-defibrillators: a case series
por: Monkhouse, Christopher, et al.
Publicado: (2019)

Efficacy and Safety of Transvenous Lead Extraction at the Time of Upgrade from Pacemakers to Cardioverter-Defibrillators and Cardiac Resynchronization Therapy
por: Stefańczyk, Paweł, et al.
Publicado: (2022)

Complications and Mortality of Single Versus Dual Chamber Implantable Cardioverter Defibrillators
por: Bagherzadeh, Ataallah, et al.
Publicado: (2006)

Pregnancy and delivery in woman with implantable cardioverter-defibrillator: what we should know
por: Bouslama, Mohamed Amine, et al.
Publicado: (2018)

Accelerated versus delayed initiation of renal-replacement strategies following cardiac surgery
por: Merritt-Genore, HelenMari, et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Anesthesia in a Child with Newly Diagnosed Hypertrophic Cardiomyopathy for Placement of Implantable Cardioverter Defibrillator
por: Kumar, Rajnish, et al.
Publicado: (2018)

Effectiveness and safety of transvenous extraction of single- versus dual-coil implantable cardioverter-defibrillator leads at single-center experience
por: Ząbek, Andrzej, et al.
Publicado: (2019)

Outcomes of single- or dual-chamber implantable cardioverter defibrillator systems in Japanese patients
por: Ueda, Akiko, et al.
Publicado: (2016)

Dual‐chamber implantable cardioverter–defibrillator. Is it useful in patient with permanent atrial fibrillation?
por: Porres‐Aracama, José M., et al.
Publicado: (2016)

Effectiveness and safety of transvenous extraction of single- versus dual-coil implantable cardioverter-defibrillator leads at single-center experience: Erratum
Publicado: (2020)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
por: Park, Yae Min
Publicado: (2023)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Recurrent shocks in a dual chamber implantable cardioverter defibrillator: Making sense of the chaos
por: Yeo, Colin, et al.
Publicado: (2018)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Single-chamber Versus Dual-chamber Implantable Cardioverter Defibrillators: Do We Need Physiologic Pacing in The Course?
por: Budeus, Marco, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_rm7t4epesr5kc44vb9kqrf2h0g